CardioClasp, Inc.

Heart failure is a huge, growing market in which devices are looking to succeed where drugs have provided only limited benefit. Paracor’s strategy is to focus first on a mechanical approach in a field

Acorn Cardiovascular: The Virtue of Patience A tough enrollment process and push back from regulators has made Acorn much later in getting to market than it once hoped. So why are company officials no

A ventricular assist device unlike any other 3130 Highland Ave., 3rd Floor Cincinnati, OH 45219 Phone: (513) 475-6629 Fax: (513) 221-1891 E-Mail/Web Site: mbyrne@cardioenergetics.com Contact: Mark Byr

In a way, five million congestive heart failure (CHF) sufferers are the victims of the success of new medical interventions developed in the past ten years. Because aspirin, clot-busting drug TPA, dev